ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Tubeimoside I Ameliorates Doxorubicin-Induced Cardiotoxicity by Upregulating SIRT3

Zhang, Wei; Fan, Zhixing; Wang, Fengyuan; Yin, Lin; Wu, Jinchun; Li, Dengke; Song, Siwei; Wang, Xi; Tang, Yanhong; Huang, Congxin*武汉大学; 1
Oxidative Medicine and Cellular Longevity2023-1-14DOI: 10.1155/2023/9966355
6被引8阅读
引用收藏
分享

摘要

Cardiotoxicity linked to doxorubicin (DOX) is primarily caused by inflammation, oxidative stress, and apoptosis. The role of tubeimoside I (TBM) in DOX-induced cardiotoxicity remains ambiguous, despite growing evidence that it could reduce inflammation, oxidative stress, and apoptosis in various diseases. This study was designed to investigate the role of TBM in DOX-induced cardiotoxicity and uncover the underlying mechanisms. H9c2 cell line and C57BL/6 mice were used to construct an in vitro and in vivo model of DOX-induced myocardial injury, respectively. We observed that DOX treatment provoked inflammation, oxidative stress, and cardiomyocyte apoptosis, which were significantly alleviated by TBM administration. Mechanistically, TBM attenuated DOX-induced downregulation of sirtuin 3 (SIRT3), and SIRT3 inhibition abrogated the beneficial effects of TBM both in vitro and in vivo. In conclusion, TBM eased inflammation, oxidative stress, and apoptosis in DOX-induced cardiotoxicity by increasing the expression of SIRT3, suggesting that it holds great promise for treating DOX-induced cardiac injury.

学科与关键词

关键词
OXIDATIVE STRESSMITOCHONDRIAL SIRT3CELL-DEATHSIRTUINSMECHANISMSINFLAMMATIONACTIVATIONDISEASESCANCERNAD(+)
相关
加载中…
  • Afzelin protects against doxorubicin-induced cardiotoxicity by promoting the AMPKα/SIRT1 signaling pathway
    Sun, Yixin; Guo, Danyang; Yue, Saiding; Zhou, Mingyan; Wang, Dongxu; Chen, Fengjiao; Wang, Lingling*Toxicology and Applied Pharmacology, 2023, 477: 116687.被引 1
  • Dihydromyricetin protects against Doxorubicin-induced cardiotoxicity through activation of AMPK/mTOR pathway
    Li, Xiaoqi; Wang, Xin; Wang, Binyu; Chi, Weiqun; Li, Zhangyi; Zhang, Min; Shen, Yifu; Liu, Xu; Lu, Youmei; Liu, Yu*PHYTOMEDICINE, 2022, 99: 154027.被引 8
  • Doxorubicin induced cardiotoxicity via inhibiting PKC-ε/SIRT1 pathway
    Liu, Danyong; He, Jianfeng; Ding, Hanlin; Wang, Chunyan; Chen, Yao; He, Junmin; Chen, Chun; Li, Yuantao; Xia, ZhengyuanAnnual meeting of the American-Society-for-Pharmacology-and-Experimental-Therapeutics (ASPET), St. Louis, MO, 2023-05-18 To 2023-05-21.
查看全部 →

发表信息

论文状态
公开发表
期刊
Oxidative Medicine and Cellular Longevity
发表日期
2023-01-14
卷期
第 2023 卷
页码
9966355
DOI
10.1155/2023/9966355
语言
ENGLISH
成果收录
SCIE
资助标注
Technical Innovation Project of Hubei Province of China [2016ACA153]; National Natural Science Foundation of China [81800258]

作者

  • Z

    Zhang, Wei (第一作者)

    wuhan univ

  • F

    Fan, Zhixing

    1 · china three gorges univ

查看全部 10 位作者收起作者
  • W

    Wang, Fengyuan

    wuhan univ

  • Y

    Yin, Lin

    wuhan univ

  • W

    Wu, Jinchun

    wuhan univ

  • L

    Li, Dengke

    wuhan univ

  • S

    Song, Siwei

    wuhan univ

  • W

    Wang, Xi

    wuhan univ

  • T

    Tang, Yanhong

    wuhan univ

  • H

    Huang, Congxin (通讯)

    wuhan univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417